MicroRNA-30b is involved in the pathological process of diabetes mellitus induced by pancreatic cancer by regulating plasminogen activator inhibitor-1

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Zeng H, et al. The updated incidences and mortalities of major cancers in China, 2011. Chin J Cancer. 2015;34(3):502–507.
   PubMedGoogle Scholar
• Andersen DK, Korc M, Petersen GM, et al. Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes 2017;66(5):1103–1110.
   PubMed Web of Science ®Google Scholar
• Korc M. Pathogenesis of pancreatic cancer-related diabetes mellitus: Quo vadis? Pancreas. 2019;48(5):594–597.
   PubMed Web of Science ®Google Scholar
• Basso D, Greco E, Fogar P, et al. Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause? Clin Chim Acta. 2006;372(1–2):120–128.
   PubMed Web of Science ®Google Scholar
• Basso D, Greco E, Fogar P, et al. Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications. Clin Chim Acta. 2005;357(2):184–189.
   PubMed Web of Science ®Google Scholar
• Valerio A, Basso D, Fogar P, et al. Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides. Clin Chim Acta. 2004;343(1–2):119–127.
   PubMed Web of Science ®Google Scholar
• Wang J, Yuan Y, Cai R, et al. Association between plasma levels of PAI-1, tPA/PAI-1 molar ratio, and mild cognitive impairment in Chinese patients with type 2 diabetes mellitus. J Alzheimers Dis. 2018;63(2):835–845.
   PubMed Web of Science ®Google Scholar
• Pieters M, Barnard SA, Loots DT, et al. The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays. PloS One. 2017 [cited 2019 Sep 18];12(2):e0171271.
   PubMed Web of Science ®Google Scholar
• Deng ZY, Shan WG, Wang SF, et al. Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats. Pharm Biol. 2017;55(1):663–672.
   PubMed Web of Science ®Google Scholar
• Inoue K. [MicroRNA function in animal development]. Tanpakushitsu kakusan koso Protein, nucleic acid, enzyme. 2007;52(3):197–204.
   PubMedGoogle Scholar
• Looney AM, Ahearne CE, Hallberg B, et al. Downstream mRNA target analysis in neonatal hypoxic-ischaemic encephalopathy identifies novel marker of severe injury: a proof of concept paper. Mol Neurobiol. 2017;54(10):8420–8428.
   PubMed Web of Science ®Google Scholar
• Ponnusamy V, Kapellou O, Yip E, et al. A study of microRNAs from dried blood spots in newborns after perinatal asphyxia: a simple and feasible biosampling method. Pediatr Res. 2016;79(5):799–805.
   PubMed Web of Science ®Google Scholar
• Looney AM, Walsh BH, Moloney G, et al. Downregulation of umbilical cord blood levels of miR-374a in neonatal hypoxic ischemic encephalopathy. J Pediatr. 2015;167(2):269–273.e2.
   PubMed Web of Science ®Google Scholar
• Zhu ED, Li N, Li BS, et al. miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1. PloS One. 2014 [cited 2019 Sep 18];9(8):e106049.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2–ΔΔCT method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Kwaan HC, Lindholm PF. Fibrin and fibrinolysis in cancer. Semin Thromb Hemost. 2019;45(4):413–422.
   PubMed Web of Science ®Google Scholar
• Conn EM, Botkjaer KA, Kupriyanova TA, et al. Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion. Am J Pathol. 2009;175(4):1638–1652.
   PubMed Web of Science ®Google Scholar
• Wei X, Li S, He J, et al. Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodeling. Cell Commun Signal. 2019 [cited 2019 Sep 18];17(1):58.
   PubMedGoogle Scholar
• Gerstein ES, Gritsaenko EV, Shcherbakov ME, et al. [Vascular endothelial growth factor and plasminogen activators in endometrial carcinoma and hyperplasia]. Vopr Onkol. 2003;49(6):725–729.
   PubMedGoogle Scholar
• Hansen S, Overgaard J, Rose C, et al. Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients. Br J Cancer. 2003;88(1):102–108.
   PubMed Web of Science ®Google Scholar
• Andreasen PA. PAI-1 - a potential therapeutic target in cancer. Curr Drug Targets. 2007;8(9):1030–1041.
   PubMed Web of Science ®Google Scholar
• Durand MK, Bodker JS, Christensen A, et al. Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis. Thromb Haemost. 2004;91(03):438–449.
   PubMedGoogle Scholar
• Li X, Gao Y, Meng Z, et al. Regulatory role of microRNA-30b and plasminogen activator inhibitor-1 in the pathogenesis of cognitive impairment. Exp Ther Med. 2016;11(5):1993–1998.
   PubMed Web of Science ®Google Scholar
• Liz J, Esteller M. lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta. 2016;1859(1):169–176.
   PubMed Web of Science ®Google Scholar
• Varshney J, Subramanian S. MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics. Front Mol Biosci. 2015 [cited 2019 Sep 18];2:31.
   PubMedGoogle Scholar
• Ouzounova M, Vuong T, Ancey PB, et al. MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells. BMC Genomics. 2013 [cited 2019 Sep 18];14(1):139.
   PubMedGoogle Scholar
• Donate PB, Fornari TA, Macedo C, et al. T cell post-transcriptional miRNA-mRNA interaction networks identify targets associated with susceptibility/resistance to collagen-induced arthritis. PloS One. 2013 [cited 2019 Sep 18];8(1):e54803.
   PubMed Web of Science ®Google Scholar
• He J, Jiang S, Li FL, et al. MicroRNA-30b-5p is involved in the regulation of cardiac hypertrophy by targeting CaMKIIdelta. J Investig Med. 2013;61(3):604–612.
   PubMed Web of Science ®Google Scholar
• Braun J, Hoang-Vu C, Dralle H, et al. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 2010;29(29):4237–4244.
   PubMed Web of Science ®Google Scholar
• Yu F, Deng H, Yao H, et al. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene. 2010;29(29):4194–4204.
   PubMed Web of Science ®Google Scholar
• Le Guillou S, Sdassi N, Laubier J, et al. Overexpression of miR-30b in the developing mouse mammary gland causes a lactation defect and delays involution. PloS One. 2012 [cited 2019 Sep 18];7(9):e45727.
   PubMed Web of Science ®Google Scholar
• Altmae S, Martinez-Conejero JA, Esteban FJ, et al. MicroRNAs miR-30b, miR-30d, and miR-494 regulate human endometrial receptivity. Reprod Sci. 2013;20(3):308–317.
   PubMed Web of Science ®Google Scholar
• Song PP, Hu Y, Liu CM, et al. Embryonic ectoderm development protein is regulated by microRNAs in human neural tube defects. Am J Obstetr Gynecol. 2011 [cited 2019 Sep 18];204(6):544.e9-17.
   PubMed Web of Science ®Google Scholar
• Gaziel-Sovran A, Segura MF, Di Micco R, et al. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell. 2011;20(1):104–118.
   PubMed Web of Science ®Google Scholar